Information platform for Japanese Medicines

LANTUS

Different Standards/Packaging Product
Log in or Sign up required.
Market information
Out of supply
Update:
Reason:
Quality problems (including contract manufacturing)
Lifting of shipments and elimination of supply is expected:
Prospects

*This information is based on information released by the Ministry of Health, Labor and Welfare. This information may not be all-inclusive. Please check with the manufacturing companies for detailed information. Please note that the supply information does not necessarily correspond to our drug supply situation, and that the supply situation is constantly changing.

Detailed information
Branded Name
LANTUS
Generic Name
Insulin Glargine (Genetical Recombination)
Heat Number / Carved Seal
N/A
Form / Color
- / -
Ministry of Health and Welfare Code
2492416A3036
YJ Code
2492416A3036
Manufacturer
Sanofi K.K.
MA holder
Sanofi K.K.
Restriction Information
Powerful drug
Storage Condition
-
Cautions for Storage
-
Brand / Authorized Generic / Generic
Brand
Biological Origin / Biosimilar
No
Strength
100 単位
Prescription Drug
Yes
Followed by Generic
not available
Effective date
000 00, 0000
Lot No.
00000000
Lead time
X days
Created at
Updated at
Log in or Sign up required.

Japanese notation

Product Name
ランタス注100単位/mL
Name of Manufacturer
サノフィ
Name of MA Holder
サノフィ
Form / Color
注射液 / -

Alternative pharmaceuticals

*About alternative pharmaceuticals...This information is based on the active ingredients, dosage form, and specifications/units. It does not necessarily mean that the product is currently available.

No alternative pharmaceuticals found.
the English trade name